Kling Douglas F

CIK 00016990222 companiesNAARDEN, P7

SEC Profile

Transactions

Companies

Filings

CIK

0001699022

Recent Transactions

50 trades

Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-07-16$10.90/sh+51,043→ 95,043 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-07-16−51,043→ 162,702 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-07-16$21.10/sh−51,043→ 44,000 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-07-15$10.90/sh+47,569→ 91,569 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-07-15$22.12/sh−3,544→ 44,000 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-07-15−47,569→ 213,745 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-07-15$21.38/sh−44,025→ 47,544 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-06-16$19.75/sh−18,109→ 44,000 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-06-16−21,899→ 261,314 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-06-16−78,101→ 372,829 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-06-16$10.90/sh+21,899→ 144,000 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-06-16$19.19/sh−81,891→ 62,109 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-06-16$10.00/sh+78,101→ 122,101 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-05-15−100,000→ 44,000 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-05-15$10.00/sh+100,000→ 144,000 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-05-15−100,000→ 450,930 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-04-15−99,090→ 44,910 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-04-15−100,000→ 550,930 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-04-15−910→ 44,000 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-04-15$10.00/sh+100,000→ 144,000 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-03-26+16,539→ 60,539 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Restricted Stock Unit
2025-03-26−16,539→ 0 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-03-26−16,539→ 44,000 total
Award
NewAmsterdam Pharma Co N.V.$NAMS
Restricted Stock Unit
2025-03-26+16,539→ 16,539 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-03-17−11,888→ 650,930 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-03-17−88,112→ 47,251 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-03-17−100,000→ 44,000 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-03-17+88,112→ 132,112 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-03-17$10.00/sh+11,888→ 144,000 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-02-19−9,218→ 126,145 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-02-19+9,218→ 53,218 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-02-19−9,218→ 44,000 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-02-18+90,782→ 134,782 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-02-18−90,782→ 44,000 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-02-18−90,782→ 135,363 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-30−4,664→ 52,914 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-30+13,578→ 57,578 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-01-30−13,578→ 226,145 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-30−8,914→ 44,000 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-29+56,863→ 100,863 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-29−56,863→ 44,000 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-01-29−56,863→ 239,723 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-28−5,148→ 44,000 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-28−20,237→ 49,148 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-01-28−25,385→ 296,586 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-28+25,385→ 69,385 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Option (right to buy)
2025-01-27−104,174→ 321,971 total
Exercise/Conversion
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-27+104,174→ 148,174 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-27−23,815→ 44,000 total
Sale
NewAmsterdam Pharma Co N.V.$NAMS
Ordinary Shares
2025-01-27−80,359→ 67,815 total

Companies

Recent Filings

Address

C/O NEWAMSTERDAM PHARMA COMPANY N.V. GOOIMEER 2-35

NAARDEN, P7, 1411 DC

View on SEC.gov